Navigation Links
BD Announces 2011 Analyst Day and Webcast
Date:10/28/2011

FRANKLIN LAKES, N.J., Oct. 28, 2011 /PRNewswire/ --  BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will host an institutional investor and analyst meeting on Wednesday, November 9, 2011, in New York City from 7:45 a.m. – 12:45 p.m. (ET).  The meeting will update the investment community on BD's corporate strategy, focusing on investing and innovating for growth.  

Live webcasts of the 90-minute General Session at 7:45 a.m. and the 30-minute Q & A Session at 12:15 p.m. will be accessible through BD's website at www.bd.com/investors.  A replay of the webcasts will be available through Wednesday, November 16, 2011.  

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:

Monique N. Dolecki, Investor Relations – 201-847-5378
Colleen T. White, Corporate Communications – 201-847-5369


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ZONARE Medical Systems Announces Appointment of PJ Ryland as Vice President of Business Development & Corporate Accounts
2. Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization
3. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
4. HeartWare International Announces Planned Departure of Chief Financial Officer
5. Omnicell Announces Third Quarter 2011 Results
6. Cardica Announces Fiscal 2012 First Quarter Financial Results
7. BioMarin Announces Third Quarter 2011 Financial Results
8. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
9. Span-America Announces Fourth Quarter and Fiscal Year-End 2011 Conference Call on the Internet
10. Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System
11. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
(Date:8/31/2015)... , Aug. 31, 2015 Thousands of people ... neglect of the opioid addiction epidemic at dozens of ... term in 2008, the United States ... addiction involving prescription opioids and heroin, yet the President ... a strongly worded letter to President Obama , ...
(Date:8/31/2015)... , August 31, 2015 ... the global cardiovascular monitoring and diagnostic devices market ... predicted to reach a value of approximately US$7.0 ... 9.7% between 2013 and 2019. The title of ... Market (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5
(Date:8/31/2015)... Cokato, MN (PRWEB) , ... August 31, 2015 , ... ... Hallmark series line of saunas. Available starting in the 3rd quarter, the newly re-styled ... that assembles quickly without special tools. , These new models include more glass and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Physicians’ Education Resource®, LLC ... Symposium: Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for ... York City. The annual legacy meeting uses a variety of formats to educate ...
(Date:8/31/2015)... Louisville, KY (PRWEB) , ... August 31, 2015 ... ... Casper, Wyoming, has selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation ... (NLP) engine, ezNLP, and a patent pending ICD-10 solution - ezCAC is an ...
(Date:8/31/2015)... ... August 31, 2015 , ... People with ... a greater risk for injury, potentially because they are more susceptible to the ... School of Public Health analysis discovered. , The research, published online in ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... users to develop skills and assess their competencies in managing challenging conversations, announced ... present at the Defense Centers of Excellence for Psychological Health and Traumatic ...
Breaking Medicine News(10 mins):Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2
... Medical Plan with Health Savings Accounts and Supplemental Coverage ... The Guardian Life Insurance Company of ... life insurers and a leading provider of employee benefits ... offering a comprehensive, high-deductible healthcare plan that helps employers ...
... will help oncologists guide treatment of patients with ... Biodesix, Inc. today announces U.S. commercial availability of ... with advanced stage non-small cell lung cancer (NSCLC). ... good or poor outcomes following treatment with epidermal ...
... Palin Will Take Part in a Town Hall Meeting ... Teen PregnancyNEW YORK, May 5 The Candie,s Foundation ... its Teen Ambassador. Palin, daughter of Governor Sarah Palin ... and select media interviews to promote May 6th, the ...
... CDC also points to encouraging developments in Mexico, thought to ... News) -- The number of confirmed swine flu cases in ... But, the revised numbers indicate catching up on a backlog ... infections, federal health officials said. , And, while insisting that ...
... Calif., May 5 The recession has forced many ... leaves concerned moms across the U.S. asking, "How will ... children isn,t so much about the quantity of time ... quality," says Dr. Robert Puff, a clinical psychologist based ...
... Automated Hemostasis Analyzer with Chemiluminescent Technology - , BEDFORD, ... that it has received FDA clearance 510(k) for the ... IL to market the ACL AcuStar Hemostasis Testing System, ... The ACL AcuStar is the first specialty-test analyzer that ...
Cached Medicine News:Health News:Guardian Launches Comprehensive, Consumer-Driven Healthcare Program 2Health News:Guardian Launches Comprehensive, Consumer-Driven Healthcare Program 3Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 2Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 3Health News:The Candie's Foundation Appoints Bristol Palin As Teen Ambassador 2Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 2Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 3Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 4Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 5Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 6Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 7Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 8Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 9Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 10Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 11Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 12Health News:Mother's Day Blues: When Being a Stay-at-Home Mom Is No Longer an Option 2Health News:Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System 2Health News:Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System 3
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: